|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400093291 |
|
最近更新日期: Date of Last Refreshed on: |
2024-12-02 11:40:54 |
|
注册时间: Date of Registration: |
2024-12-02 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于用户体验优化的乳腺癌患者康复期体力活动精准移动医疗干预模式研究 |
|
Public title: |
Study on precise mobile health intervention based on user experience optimization of physical activity in breast cancer rehabilitation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于用户体验优化的乳腺癌患者康复期体力活动精准移动医疗精准干预模式研究 |
|
Scientific title: |
Study on precise mobile health intervention based on user experience optimization of physical activity in breast cancer rehabilitation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
叶文佳 |
研究负责人: |
耿朝辉 |
|
Applicant: |
Ye Wenjia |
Study leader: |
Geng Zhaohui |
|
申请注册联系人电话: Applicant telephone: |
+86 150 0081 4683 |
研究负责人电话:
Study leader's |
+86 152 2195 6608 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
ywjiazi@163.com |
研究负责人电子邮件: Study leader's E-mail: |
gengzh200890@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市虹口区甘河路110号 |
研究负责人通讯地址: |
上海市浦东新区蔡伦路1200号 |
|
Applicant address: |
No. 110 Ganhe Road, Hongkou District, Shanghai |
Study leader's address: |
No. 1200 Cailun Road, Pudong New District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
200437 |
研究负责人邮政编码: Study leader's postcode: |
201203 |
|
申请人所在单位: |
上海中医药大学附属岳阳中西医结合医院 |
||
|
Applicant's institution: |
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
上海中医药大学护理学院 |
||
|
Affiliation of the Leader: |
School of Nursing, Shanghai University of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023-1-5-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海中医药大学医学伦理委员会 |
||
|
Name of the ethic committee: |
IRB of Shanghai University of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-05-22 00:00:00 | ||
|
伦理委员会联系人: |
朱惠蓉 |
||
|
Contact Name of the ethic committee: |
Zhu Huirong |
||
|
伦理委员会联系地址: |
上海市浦东新区蔡伦路1200号 |
||
|
Contact Address of the ethic committee: |
No. 1200 Cailun Road, Pudong New District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 5132 2012 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
kyetem@vip.sina.com |
|
研究实施负责(组长)单位: |
上海中医药大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai University of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市浦东新区蔡伦路1200号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1200 Cailun Road, Pudong New District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China |
||||||||||||||||||||||
|
研究疾病: |
乳腺癌 |
||||||||||||||||||||||
|
Target disease: |
breast cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
促进乳腺癌患者体力活动行为改变,提升患者自主体力活动管理的参与度与体验。 |
||||||||||||||||||||||
|
Objectives of Study: |
To promote physical activity behavior of breast cancer patients, and improve the participation and user experience on autonomous physical activity management of patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄≥18岁; 2.首次诊断为浸润性乳腺癌,且完成乳腺癌根治性手术者; 3.经乳腺科医生和康复科医生评估为适合参加本项目者; 4.文化程度为小学及以上; 5.能够日常使用智能手机端微信; 6.自愿参与并知情同意者。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Aged >= 18 years; 2.Adults diagnosed with invasive breast cancer for the first time and completed radical mastectomy; 3.Evaluated by breast surgeons and physical therapist as suitable for the program; 4.Educational background of elementary school and above; 5.Ability to use a smart phone to access the internet; 6.Voluntary participation in research after informed. |
||||||||||||||||||||||
|
排除标准: |
1.患有认知性障碍或视力障碍的疾病; 2.有除原发性乳腺癌以外的其他恶性肿瘤病史及合并心血管、肝、肾、神经、代谢性、造血等严重基础疾病; 3.具有骨、关节疾病影响其日常体力活动; 4.乳腺癌晚期或复发患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Suffering from cognitive impairment or visual impairment; 2. A history of malignant tumors other than primary breast cancer combined with cardiovascular, liver, kidney, neurological, metabolic, hematopoietic and other serious underlying diseases; 3. Patients with bone and joint diseases affecting daily physical activity; 4. Patients with advanced or recurrent breast cancer. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-07-18 00:00:00至 To 2025-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-07-18 00:00:00 至 To 2025-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用随机数生成网站生成随机数 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Generation of random number by random number series website |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
使用单盲法,测量者不知晓分组 |
|
Blinding: |
Single blind, the outcome assessor is unaware of the grouping |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
如有需要可联系课题组获取原始数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Contact our research team to obtain the original data if needed. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
通过医院的病历系统进行数据的采集,运用Epidata管理分析数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data were collected through the hospital's medical record system, and Epidata was used to manage and analyze the data. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |